70 related articles for article (PubMed ID: 16000677)
1. Does somatosensory amplification decrease with antidepressant treatment?
Sayar K; Barsky AJ; Gulec H
Psychosomatics; 2005; 46(4):340-4. PubMed ID: 16000677
[TBL] [Abstract][Full Text] [Related]
2. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
3. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population.
Wolfe F; Brähler E; Hinz A; Häuser W
Arthritis Care Res (Hoboken); 2013 May; 65(5):777-85. PubMed ID: 23424058
[TBL] [Abstract][Full Text] [Related]
4. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
5. Residual anxiety symptoms in depressed primary care patients.
McIntyre RS; Konarski JZ; Soczynska JK; Kennedy SH
J Psychiatr Pract; 2007 Mar; 13(2):125-8. PubMed ID: 17414691
[TBL] [Abstract][Full Text] [Related]
6. A clinically useful depression outcome scale.
Zimmerman M; Chelminski I; McGlinchey JB; Posternak MA
Compr Psychiatry; 2008; 49(2):131-40. PubMed ID: 18243884
[TBL] [Abstract][Full Text] [Related]
7. Can people with nonsevere major depression benefit from antidepressant medication?
Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
[TBL] [Abstract][Full Text] [Related]
8. No effect of antidepressant treatment on elevated serum ceruloplasmin level in patients with first-episode depression: a longitudinal study.
Kaya MC; Bez Y; Selek S; Fatih Karababa I; Bulut M; Savaş HA; Celik H; Herken H
Arch Med Res; 2012 May; 43(4):294-7. PubMed ID: 22704847
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
10. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
Arnold LM; Palmer RH; Gendreau RM; Chen W
Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218
[TBL] [Abstract][Full Text] [Related]
11. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
[TBL] [Abstract][Full Text] [Related]
13. Substance P in serum and cerebrospinal fluid of depressed patients: no effect of antidepressant treatment.
Deuschle M; Sander P; Herpfer I; Fiebich BL; Heuser I; Lieb K
Psychiatry Res; 2005 Jul; 136(1):1-6. PubMed ID: 16024091
[TBL] [Abstract][Full Text] [Related]
14. Sexual dysfunction and physicians' perception in medicated patients with major depression in Taiwan.
Chen KC; Yang YK; Lee IH; Yeh TL; Lu RB; Chen PS
Depress Anxiety; 2008; 25(9):E56-62. PubMed ID: 17551923
[TBL] [Abstract][Full Text] [Related]
15. [Fatigued or depressed?].
Pouchain D
Encephale; 2008 Jun; 34 Spec No 2():S17-20. PubMed ID: 18694668
[No Abstract] [Full Text] [Related]
16. Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.
Van HL; Dekker J; Peen J; van Aalst G; Schoevers RA
Psychother Psychosom; 2008; 77(6):358-64. PubMed ID: 18701832
[TBL] [Abstract][Full Text] [Related]
17. The level of recognition of physical symptoms in patients with a major depression episode in the outpatient psychiatric practice in Puerto Rico: an observational study.
Tamayo JM; Román K; Fumero JJ; Rivas M
BMC Psychiatry; 2005 Jun; 5():28. PubMed ID: 15967039
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
[TBL] [Abstract][Full Text] [Related]
19. Alexithymia, fear of bodily sensations, and somatosensory amplification in young outpatients with panic disorder.
De Berardis D; Campanella D; Gambi F; La Rovere R; Sepede G; Core L; Canfora G; Santilli E; Valchera A; Mancini E; Salerno RM; Moschetta FS; Ferro FM
Psychosomatics; 2007; 48(3):239-46. PubMed ID: 17478593
[TBL] [Abstract][Full Text] [Related]
20. Treating partial responders to antidepressant treatment.
Trivedi MH
J Clin Psychiatry; 2009 Sep; 70(9):e31. PubMed ID: 19818237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
